The risk of upper gastrointestinal (GI) adverse events of patients switching from risedronate to alendronate after the introduction of generic alendronate products in the UK

S. H. Ralston; T. D. Kou; B. C. Wick-Urban; M. Steinbuch

doi:10.1016/j.bone.2009.01.252

The risk of upper gastrointestinal (GI) adverse events of patients switching from risedronate to alendronate after the introduction of generic alendronate products in the UK

S. H. Ralston
, T. D. Kou
, B. C. Wick-Urban
, M. Steinbuch

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	S114-S115
Number of pages	2
Journal	Bone
Volume	44
DOIs	https://doi.org/10.1016/j.bone.2009.01.252
Publication status	Published - May 2009

Access to Document

10.1016/j.bone.2009.01.252

Cite this

@article{c80a19eaf7e2497bbafbc08f0b9d0850,

title = "The risk of upper gastrointestinal (GI) adverse events of patients switching from risedronate to alendronate after the introduction of generic alendronate products in the UK",

author = "Ralston, \{S. H.\} and Kou, \{T. D.\} and Wick-Urban, \{B. C.\} and M. Steinbuch",

year = "2009",

month = may,

doi = "10.1016/j.bone.2009.01.252",

language = "English",

volume = "44",

pages = "S114--S115",

journal = "Bone",

issn = "8756-3282",

publisher = "Elsevier",

}

TY - JOUR

T1 - The risk of upper gastrointestinal (GI) adverse events of patients switching from risedronate to alendronate after the introduction of generic alendronate products in the UK

AU - Ralston, S. H.

AU - Kou, T. D.

AU - Wick-Urban, B. C.

AU - Steinbuch, M.

PY - 2009/5

Y1 - 2009/5

U2 - 10.1016/j.bone.2009.01.252

DO - 10.1016/j.bone.2009.01.252

M3 - Meeting abstract

SN - 8756-3282

VL - 44

SP - S114-S115

JO - Bone

JF - Bone

ER -